(Q34443175)

2 August 2017

1 reference

title

Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target (English)

1 reference

2 August 2017

0 references

1 reference

coronary artery disease

1 reference

C H Macphee

1

1 reference

2 August 2017

publication date

1 April 2001

1 reference

Current Opinion in Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

121-125

1 reference

Atherosclerosis — An Inflammatory Disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

The oxidative modification hypothesis of atherogenesis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Infection and inflammation-induced proatherogenic changes of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Metabolism of oxidized LDL by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

The pathophysiology of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Novel inflammatory markers of coronary risk: theory versus practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Inflammation markers and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Infection and inflammation induce LDL oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Mechanism of inhibition of LDL phospholipase A2 by monocyclic-beta-lactams. Burst kinetics and the effect of stereochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Platelet-activating factor and related lipid mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900024-8

7 January 2021

10.1016/S1471-4892(01)00024-8

Identifiers

DOI

1 reference

2 August 2017

1 reference